Will Three Be The Charm For FDA Review Of Antipsychotics For Pediatric Use?
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Psychopharmacologic Drugs Advisory Committee will evaluate pediatric indications for AstraZeneca’s Seroquel, Pfizer’s Geodon and Lilly’s Zyprexa during its June 9-10 meeting.